home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

269 rows where has_known_aptamer = 0 and surface_class = "A_assoc" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: pdb_count_total

tier 2

  • Tier 1.5 177
  • Tier 1 92

in_cev_map 2

  • 0 171
  • 1 98

has_structure 2

  • 1 164
  • 0 105

has_cryoEM 2

  • 0 225
  • 1 44

surface_class 1

  • A_assoc · 269 ✖

has_known_aptamer 1

  • - · 269 ✖

has_activation_state_pdb_pair 1

  • 0 269
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P12883 MYH7 Myosin-7 Tier 1 0.871 1 A_assoc 43 74.25 1 0     0 0   1 hypertrophic cardiomyopathy 0.9029865147265421
P02462 COL4A1 Collagen alpha-1(IV) chain Tier 1.5 0.854 1 A_assoc 4 48.47 0 0     0 0   1 brain small vessel disease 1 with or without ocular anomalies 0.84655287380359
P03951 F11 Coagulation factor XI Tier 1 0.853 1 A_assoc 100 86.88 0 0     0 0   1 factor XI deficiency 0.841884208404384
P04180 LCAT Phosphatidylcholine-sterol acyltransferase Tier 1.5 0.848 1 A_assoc 7 86.75 1 0     0 0   1 Fish-eye disease 0.8273460309828392
Q15582 TGFBI Transforming growth factor-beta-induced protein ig-h3 Tier 1.5 0.847 1 A_assoc 10 90.25 1 0     0 0   1 lattice corneal dystrophy type I 0.8242841141270143
P07942 LAMB1 Laminin subunit beta-1 Tier 1.5 0.84 1 A_assoc 3 76.69 1 0     0 0   1 cobblestone lissencephaly without muscular or ocular involvement 0.8016665947624902
Q9BWP8 COLEC11 Collectin-11 Tier 1 0.839 1 A_assoc 3 78.31 0 0     0 0   1 3MC syndrome 2 0.7977893521540559
P20908 COL5A1 Collagen alpha-1(V) chain Tier 1 0.839 1 A_assoc 1 51.25 0 0     0 0   1 Ehlers-Danlos syndrome, classic type, 1 0.7979601586599098
P02671 FGA Fibrinogen alpha chain Tier 1 0.838 1 A_assoc 40 60.34 0 0     0 0   1 familial dysfibrinogenemia 0.7947496460990987
P00488 F13A1 Coagulation factor XIII A chain Tier 1 0.838 1 A_assoc 15 90.88 1 0     0 0   1 Factor XIII subunit A deficiency 0.7939842013132387
P22105 TNXB Tenascin-X Tier 1.5 0.837 1 A_assoc 3 87.81 0 0     0 0   1 Ehlers-Danlos syndrome due to tenascin-X deficiency 0.7916412481554758
P13645 KRT10 Keratin, type I cytoskeletal 10 Tier 1 0.836 1 A_assoc 6 64.31 0 0     0 0   1 epidermolytic hyperkeratosis 2A, autosomal dominant 0.7860749239386174
Q12904 AIMP1 Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 Tier 1 0.834 1 A_assoc 6 81.12 0 0     0 0   1 hypomyelinating leukodystrophy 3 0.7806847123659254
O43707 ACTN4 Alpha-actinin-4 Tier 1 0.833 1 A_assoc 5 84.12 0 0     0 0   1 focal segmental glomerulosclerosis 1 0.7778533437264424
P35858 IGFALS Insulin-like growth factor-binding protein complex acid labile subunit Tier 1.5 0.833 1 A_assoc 1 90.56 1 0     0 0   1 Reduced insulin like growth factor binding protein acid labile subunit concentration 0.7760522769257892
O15230 LAMA5 Laminin subunit alpha-5 Tier 1.5 0.828 1 A_assoc 2 79.12 1 0     0 0   1 nephrotic syndrome, IIa 26 0.7594872666460903
P08572 COL4A2 Collagen alpha-2(IV) chain Tier 1.5 0.819 1 A_assoc 4 47.25 0 0     0 0   1 porencephaly 2 0.7294975109351518
O60568 PLOD3 Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 Tier 1.5 0.815 1 A_assoc 18 91.38 1 0     0 0   1 bone fragility with contractures, arterial rupture, and deafness 0.7159150369336311
P48200 IREB2 Iron-responsive element-binding protein 2 Tier 1 0.799 1 A_assoc 1 86.75 1 0     0 0   1 neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia 0.664403876125082
P02745 C1QA Complement C1q subcomponent subunit A Tier 1 0.79 1 A_assoc 11 82.62 1 0     0 0   1 C1Q deficiency 1 0.6319053256658114
P02747 C1QC Complement C1q subcomponent subunit C Tier 1 0.787 1 A_assoc 11 80.56 1 0     0 0   1 C1Q deficiency 0.6233532074390745
Q9Y6C2 EMILIN1 EMILIN-1 Tier 1.5 0.786 1 A_assoc 2 62.91 0 0     0 0   1 arterial tortuosity-bone fragility syndrome 0.6185329512431467
P49767 VEGFC Vascular endothelial growth factor C Tier 1.5 0.785 1 A_assoc 4 73.19 0 0     0 0   1 Milroy disease 0.6170524106764851
P09486 SPARC SPARC Tier 1 0.784 1 A_assoc 4 84.31 0 0     0 0   1 osteogenesis imperfecta 0.6138892200186172
P04746 AMY2A Pancreatic alpha-amylase Tier 1 0.78 1 A_assoc 51 96.75 0 0     0 0   1 type 2 diabetes mellitus 0.5997984923419163
O00622 CCN1 CCN family member 1 Tier 1.5 0.765 1 A_assoc 2 73.12 0 0     0 0   1 Abnormality of the skeletal system 0.5505331194769112
P02749 APOH Beta-2-glycoprotein 1 Tier 1 0.764 1 A_assoc 14 93.12 0 0     0 0   1 atrial fibrillation 0.5456247991985232
A8K2U0 A2ML1 Alpha-2-macroglobulin-like protein 1 Tier 1 0.764 1 A_assoc 5 80.5 1 0     0 0   1 Otitis media 0.5479914512784171
P20061 TCN1 Transcobalamin-1 Tier 1 0.763 1 A_assoc 2 89.12 0 0     0 0   1 vitamin B deficiency 0.5449702229454368
Q68CZ2 TNS3 Tensin-3 Tier 1.5 0.762 1 A_assoc 1 56.81 0 0     0 0   1 neurodegenerative disease 0.539772721274482
Q14766 LTBP1 Latent-transforming growth factor beta-binding protein 1 Tier 1 0.754 1 A_assoc 1 58.88 0 0     0 0   1 Abnormality of the skeletal system 0.5142669818409414
Q9Y3B8 REXO2 Oligoribonuclease, mitochondrial Tier 1.5 0.754 1 A_assoc 10 88.19 0 0     0 0   1 neurodegenerative disease 0.5134178677464454
P36980 CFHR2 Complement factor H-related protein 2 Tier 1.5 0.753 1 A_assoc 4 90.62 0 0     0 0   1 age-related macular degeneration 0.5100732932209376
Q08043 ACTN3 Alpha-actinin-3 Tier 1 0.752 1 A_assoc 3 84.19 1 0     0 0   1 Abnormality of the skeletal system 0.5080072819822437
Q9H792 PEAK1 Inactive tyrosine-protein kinase PEAK1 Tier 1 0.752 1 A_assoc 2 48.03 0 0     0 0   1 type 2 diabetes mellitus 0.5080681892268507
Q04756 HGFAC Hepatocyte growth factor activator serine protease Tier 1 0.747 1 A_assoc 7 75.31 0 0     0 0   1 metabolic disease 0.4900675680377984
Q9UM22 EPDR1 Mammalian ependymin-related protein 1 Tier 1 0.746 1 A_assoc 3 85.88 0 0     0 0   1 Dupuytren Contracture 0.48568453021554975
Q07157 TJP1 Tight junction protein 1 Tier 1 0.741 1 A_assoc 19 54.62 0 0     0 0   1 dengue disease 0.47083190223446686
P05161 ISG15 Ubiquitin-like protein ISG15 Tier 1 0.74 1 A_assoc 22 85.88 1 0     0 0   1 COVID-19 0.4668295741563516
P0DUB6 AMY1A Alpha-amylase 1A Tier 1 0.738 1 A_assoc 13 96.69 0 0     0 0   1 dentures 0.4597705945086364
Q9NR12 PDLIM7 PDZ and LIM domain protein 7 Tier 1 0.738 1 A_assoc 2 70.25 0 0     0 0   1 neurodegenerative disease 0.4602637679250804
Q13177 PAK2 Serine/threonine-protein kinase PAK 2 Tier 1.5 0.736 1 A_assoc 5 74.62 0 0     0 0   1 Knobloch syndrome 0.45371318009439854
Q13625 TP53BP2 Apoptosis-stimulating of p53 protein 2 Tier 1.5 0.735 1 A_assoc 6 58.97 0 0     0 0   1 neurodegenerative disease 0.4484066399496438
Q9BVC4 MLST8 Target of rapamycin complex subunit LST8 Tier 1 0.733 1 A_assoc 45 91.62 1 0     0 0   1 neurodegenerative disease 0.4440338170862142
P19827 ITIH1 Inter-alpha-trypsin inhibitor heavy chain H1 Tier 1 0.731 1 A_assoc 2 87.44 0 0     0 0   1 osteoarthritis, hip 0.4360348893142765
Q92187 ST8SIA4 CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase Tier 1 0.731 1 A_assoc 3 86.44 0 0     0 0   1 systemic lupus erythematosus 0.43832763677821385
Q9UKU9 ANGPTL2 Angiopoietin-related protein 2 Tier 1.5 0.727 1 A_assoc 1 78.19 0 0     0 0   1 Abnormality of the skeletal system 0.4235882639081519
Q96SL4 GPX7 Glutathione peroxidase 7 Tier 1.5 0.721 1 A_assoc 1 92.69 0 0     0 0   1 Abnormality of the skeletal system 0.40349356855524837
Q14192 FHL2 Four and a half LIM domains protein 2 Tier 1 0.711 1 A_assoc 4 92.06 0 0     0 0   1 familial isolated dilated cardiomyopathy 0.3714277539581253
Q16627 CCL14 C-C motif chemokine 14 Tier 1.5 0.711 1 A_assoc 2 85.38 0 0     0 0   1 neurodegenerative disease 0.37013422446672883

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 784.271ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target